Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension

Hepatology Research

Volumn 32, Issue 2, 2005, Pages 107-116

  Ikura, Yoshihiro ^a   Ohsawa, Masahiko ^a   Shirai, Nobuyuki ^a   Sugama, Yoshimi ^a   Fukushima, Hiroko ^a   Suekane, Takehisa ^a   Hirayama, Michihiko ^a   Ehara, Shoichi ^a   Naruko, Takahiko ^b   Ueda, Makiko ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Angiotensin II type 1 receptor (AT1); Angiotensin converting enzyme (ACE); Liver cirrhosis; Mast cell chymase; Portal hypertension

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CHYMASE; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA;

ADULT; AGED; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LIVER BIOPSY; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; MAST CELL; MORPHOMETRICS; MYOFIBROBLAST; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; STELLATE CELL; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 21744453693     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2005.01.017     Document Type: Article

References (41)

1. W.F. Ganong Endocrine functions of the kidneys, heart, and pineal gland In: Review of medical physiology 20 2001 McGraw-Hill New York p. 439-451
2. S.A. Mezzano M. Ruiz-Ortega J. Egido Angiotensin II and renal fibrosis Hypertension 38 2001 635-638
3. T. Inagami Y. Kitami Angiotensin II receptor: Molecular cloning, functions, and regulation Hypertens Res 17 1994 87-97
4. G. Paizis R.E. Gilbert M.E. Cooper et al. Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis J Hepatol 35 2001 376-385
5. H. Yoshiji S. Kuriyama J. Yoshii et al. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats Hepatology 34 2001 745-750
6. G. Paizis M.E. Cooper J.M. Schembri C. Tikellis L.M. Burrell P.W. Angus Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver Gastroenterology 123 2002 1667-1676
7. R. Bataller P. Sancho-Bru P. Gines et al. Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II Gastroenterology 125 2003 117-125
8. J. Vlachogiannakos A.K. Tang D. Patch A.K. Burroughs Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease Gut 49 2001 303-338
9. D.C. Rockey Vasoactive agents in intrahepatic portal hypertension and fibrogenesis: Implications for therapy Gastroenterology 118 2000 1261-1265
10. A.W. Schneider J.F. Kalk C.P. Klein Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis Hepatology 29 1999 334-339
11. Y. Terui T. Saito H. Watanabe et al. Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C Hepatology 36 2002 1022
12. J. Gonzalez-Abraldes A. Albillos R. Banares Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis Gastroenterology 121 2001 382-388
13. M. Schepke E. Werner E. Biecker et al. Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension Gastroenterology 121 2001 389-395
14. F. Tabak A. Mert R. Ozaras et al. Losartan-induced hepatic injury J Clin Gastroenterol 34 2002 585-586
15. C.P. Campanile J.K. Crane M.J. Peach J.C. Garrison The hepatic angiotensin II receptor. I. Characterization of the membrane-binding site and correlation with physiological response in hepatocytes J Biol Chem 257 1982 4951-4958
16. J.A. Garcia-Sainz M. Martinez-Alfaro M.T. Romero-Avila C. Gonzalez-Espinosa Characterization of the AT1 angiotensin II receptor expressed in guinea pig liver J Endocrinol 154 1997 133-138
17. R. Bataller P. Gines J.M. Nicolas et al. Angiotensin II induces contraction and proliferation of human hepatic stellate cells Gastroenterology 118 2000 1149-1156
18. Y. Kamada S. Tamura S. Kiso et al. Angiotensin II stimulates the nuclear translocation of Smad2 and induces PAI-1 mRNA in rat hepatic stellate cells Hepatol Res 25 2003 296-305
19. K.K. Ng J.R. Vane Fate of angiotensin I in the circulation Nature 218 1968 144-150
20. H. Urata A. Kinoshita K.S. Misono F.M. Bumpus A. Husain Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart J Biol Chem 265 1990 22348-22357
21. A. MaassenVanDenBrink R. de Vries P.R. Saxena M.A. Schalekamp A.H. Danser Vasoconstriction by in situ formed angiotensin II: Role of ACE and chymase Cardiovasc Res 44 1999 407-415
22. Y. Matsunaga T. Terada Mast cell subpopulations in chronic inflammatory hepatobiliary diseases Liver 20 2000 152-156
23. W. Koda K. Harada K. Tsuneyama et al. Evidence of the participation of peribiliary mast cells in regulation of the peribiliary vascular plexus along the intrahepatic biliary tree Lab Invest 80 2000 1007-1017
24. K. Ishak A. Baptista L. Bianchi et al. Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696-699
25. H. Rakugi A. Okamura K. Kamide et al. Recognition of tissue- and subtype-specific modulation of angiotensin II receptors using antibodies against AT1 and AT2 receptors Hypertens Res 20 1997 51-55
26. M. Ohishi M. Ueda H. Rakugi et al. Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans Circulation 96 1997 3328-3337
27. C.M. van der Loos A.E. Becker J.J. van den Oord Practical suggestions for successful immunoenzyme double-staining experiments Histochem J 25 1993 1-13
28. C. Pilette M.C. Rousselet P. Bedossa et al. Histopathological evaluation of liver fibrosis: Quantitative image analysis vs semi-quantitative scores. Comparison with serum markers J Hepatol 28 1998 439-446
29. T. Caballero A. Perez-Milena M. Masseroli et al. Liver fibrosis assessment with semiquantitative indexes and image analysis quantification in sustained-responder and non-responder interferon-treated patients with chronic hepatitis C J Hepatol 34 2001 740-747
30. Y. Ikura M. Ohsawa T. Naruko et al. Expression of the hepatic endothelin system in human cirrhotic livers J Pathol 204 2004 304-310
31. T.D. Boyer Pharmacologic treatment of portal hypertension: Past, present, and future Hepatology 34 2001 834-839
32. N. Hirooka I. Iwasaki H. Horie G. Ide Hepatic microcirculation of liver cirrhosis studied by corrosion cast/scanning electron microscope examination Acta Pathol Jpn 36 1986 375-387
33. Y. Nakanuma M. Sasaki N. Kono Succinylated wheat germ agglutinin lectin binding in intrahepatic vessels. A new histochemical tool Arch Pathol Lab Med 117 1993 809-811
34. D.C. Rockey C.N. Housset S.L. Friedman Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo J Clin Invest 92 1993 1795-1804
35. J.R. Jonsson A.D. Clouston Y. Ando et al. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis Gastroenterology 121 2001 148-155
36. S.G. Ramos A.P. Montenegro G. Goissis M.A. Rossi Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum-induced rat liver fibrosis Pathol Int 44 1994 655-661
37. N. Sedlaczek J.D. Jia M. Bauer et al. Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis Am J Pathol 158 2001 1239-1244
38. L.G. Bianciotti M.S. Vatta A.E. Dominguez et al. Quantitative modifications induced by angiotensin II on rat bile secretion Regul Pept 54 1994 429-437
39. K. Asano D.L. Dutcher J.D. Port et al. Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium Circulation 95 1997 1193-1200
40. E. Hai Y. Ikura T. Naruko et al. Alterations of endothelin-converting enzyme expression in early and advanced stages of human coronary atherosclerosis Int J Mol Med 13 2004 649-654
41. H. Matsubara Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases Circ Res 83 1998 1182-1191